Paradromics is developing brain-machine interface (BMI) technology that is designed to allow patients with severe connectivity disorders such as blindness, deafness and paralysis to reconnect with the outside world using advanced prosthetic devices. One of the initial applications of this potentially life-changing technology will be to enable locked-in patients who are unable to fluently communicate, to speak again in real time via the aid of a computer.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/14/18 | $7,000,000 | Seed |
Alpha Edison Arkitekt Ventures  Deepwater Asset Management Dolby Family Ventures Fusion Fund IT-Farm Synergy Ventures | undisclosed |
| 07/22/21 | $20,000,000 | Seed |
Alpha Edison Dolby Family Ventures IT-Farm Prime Movers Lab Pureland Global Ventures Synergy Ventures Westcott Investment Group | undisclosed |
| 05/18/23 | $33,000,000 | Series A |
Dolby Family Ventures Green Sands Equity Prime Movers Lab Westcott Investment Group | undisclosed |
